Stock-Based Compensation for IQVIA (IQV)
Stock-Based Compensation for IQVIA (IQV): headline value $187.00M · YoY +19.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
IQV
Currently viewingStock-Based CompensationSwitch metric
Latest period
$187.00M
YoY change
+19.9%
5Y CAGR
+21.1%
Peak year (2025)
$247.00M
Latest annual
$247.00M
Stock-Based Compensation history chart for IQVIA (IQV) from 2010 to 2025
Stock-Based Compensation history table for IQVIA (IQV) from 2010 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $247.00M | +19.9% | ||
| 2024 | $206.00M | -5.1% | ||
| 2023 | $217.00M | +11.9% | ||
| 2022 | $194.00M | +14.1% | ||
| 2021 | $170.00M | +78.9% | ||
| 2020 | $95.00M | -34.9% | ||
| 2019 | $146.00M | +29.2% | ||
| 2018 | $113.00M | +6.6% | ||
| 2017 | $106.00M | +32.5% | ||
| 2016 | $80.00M | +111.9% | ||
| 2015 | $37.76M | +25.9% | ||
| 2014 | $30.00M | +31.4% | ||
| 2013 | $22.83M | -12.0% | ||
| 2012 | $25.93M | +83.5% | ||
| 2011 | $14.13M | -18.5% | ||
| 2010 | $17.33M | — |
Stock-Based Compensation values are taken from IQVIA's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, IQVIA (IQV) reported stock-based compensation of $247.00M – grew 19.9% year-over-year.
Across 2020–2025 (5 years), IQVIA stock-based compensation produced a CAGR of +21.1% – with the latest reading among the more recent periods of the dataset.
The highest annual stock-based compensation of $247.00M was reported in 2025. The lowest in the available history was $14.13M in 2011.
IQVIA (IQV) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
IQVIA Stock-Based Compensation by Year
IQVIA Stock-Based Compensation 2025: $247.00M
IQVIA stock-based compensation in 2025 was $247.00M, grew 19.9% from 2024. This figure represents the highest annual value in the available history.
IQVIA Stock-Based Compensation 2024: $206.00M
IQVIA stock-based compensation in 2024 was $206.00M, declined 5.1% below 2023.
IQVIA Stock-Based Compensation 2023: $217.00M
IQVIA stock-based compensation in 2023 was $217.00M, grew 11.9% from 2022.
IQVIA Stock-Based Compensation 2022: $194.00M
IQVIA stock-based compensation in 2022 was $194.00M, grew 14.1% from 2021.
IQVIA Stock-Based Compensation 2021: $170.00M
IQVIA stock-based compensation in 2021 was $170.00M.
See more financial history for IQVIA (IQV).
Sector peers — Stock-Based Compensation
Companies in the same sector as IQVIA, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is IQVIA's stock-based compensation?
Latest reported stock-based compensation for IQVIA (IQV) is $187.00M (period ending December 31, 2025).
How has IQVIA stock-based compensation changed year-over-year?
IQVIA (IQV) stock-based compensation changed +19.9% year-over-year on the latest annual filing.
What is the long-term growth rate of IQVIA stock-based compensation?
IQVIA (IQV) stock-based compensation compound annual growth rate is +21.1% over the most recent 5 years available.
When did IQVIA stock-based compensation hit its highest annual value?
IQVIA stock-based compensation reached its highest annual value of $247.00M in 2025.
What was IQVIA stock-based compensation in 2024?
IQVIA (IQV) stock-based compensation in 2024 was $206.00M.
What was IQVIA stock-based compensation in 2025?
IQVIA (IQV) stock-based compensation in 2025 was $247.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
IQV Overview
Company profile, financial tools, and key metrics
IQV Revenue Counter
Earns $517.19 every second. See per minute, hour, and day.
IQV Earnings Counter
Earns $43.13 per second net profit. See per minute, hour, and day.
IQV Economic Scale
Exceeds Bahamas, The's GDP. Compare with world economies.
IQV What If Invested
What if you had invested $1,000? See historical returns from any date.
IQV How It Makes Money
Discover visual breakdown of $16.31B in revenue — where it comes from and where it goes.
IQV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IQV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IQV Daily Price Character
Steady · 51.4% historical win rate (green days). Streaks & record days.
IQV Buybacks
5.94% TTM buyback yield. Shareholder yield & SBC comparison.